Key result
Genetic screening identifies pathogenic variants in ~75% of congenital LQTS cases, predominantly in KCNQ1.
Why the study?
What are the genetic mutation frequencies and clinical genotype-phenotype characteristics of congenital long QT syndrome in a Thai cohort?
Cohort (n=20)
No
What are the genetic mutation frequencies and clinical genotype-phenotype characteristics of congenital long QT syndrome in a Thai cohort?
This first genotype-phenotype characterization of congenital LQTS in Thailand demonstrates that 71% of families harbor pathogenic or likely pathogenic variants in KCNQ1 (35%), KCNH2 (24%), or SCN5A (12%), with LQT2 and LQT3 patients predominantly experiencing cardiac events at rest or sleep.
Answers are grounded in this paper and cite their sources.
May inform genetic testing strategies in Thai LQTS; extends prior genotype data to a Southeast Asian cohort.
BACKGROUND: Congenital long QT syndrome (LQTS) is an inheritable arrhythmic disorder which is linked to at least 17 genes. The clinical characteristics and genetic mutations may be variable among different population groups and they have not yet been studied in Thai population. METHODS: Clinical characteristics were retrospectively reviewed from children and young adults with congenital long QT syndrome whose blood samples were sent for genotyping during 1998-2017. Sangers sequencing was used to sequentially identify KCNQ1 or KCNH2 genetic variants. Whole exome sequencing (WES) was used to identify variants in all other known LQTS genes. RESULTS: Of the 20 subjects (17 families), 45% were male, mean QTc was 550.3 ± 68.8 msec (range 470-731 msec) and total Schwartz's score was 5.6 ± 1.2 points (range 3-8 points). Fifty percent of patients had events at rest, 30% had symptoms after adrenergic mediated events, and 20% were asymptomatic. We discovered pathogenic and likely pathogenic genetic variants in KCNQ1, KCNH2, and SCN5A in 6 (35%), 4 (24%), and 2 (12%) families, respectively. One additional patient had variance of unknown significance (VUS) in KCNH2 and another one in ANK2. No pathogenic genetic variant was found in 3 patients (18%). Most patients received beta-blocker and 9 (45%) had ICD implanted. LQT1 patients were either asymptomatic or had stress-induced arrhythmia. Most of the LQT2 and LQT3 patients developed symptoms at rest or during sleep. CONCLUSIONS: Our patients with LQTS were mostly symptomatic at presentation. The genetic mutations were predominantly in LQT1, LQT2, and LQT3 genes.
No takes yet. Share an insight, caveat, or question.
Saprungruang et al. (2018) conducted a cohort in Congenital long QT syndrome (LQTS) (n=20). Genetic testing (Sanger sequencing of KCNQ1/KCNH2 followed by whole exome sequencing of 17 LQTS genes) was evaluated on Prevalence of pathogenic or likely pathogenic genetic variants in known LQTS genes. Genetic testing in 17 Thai families (20 patients) with congenital LQTS identified pathogenic or likely pathogenic variants in KCNQ1, KCNH2, and SCN5A.
Synapse has enriched 10 related papers. Consider them for comparative context: